Froese J, Mandalari M, Civera M, Elli S, Pagani I, Vicenzi E
Sci Rep. 2024; 14(1):32174.
PMID: 39741163
PMC: 11688500.
DOI: 10.1038/s41598-024-84276-5.
Handa K, Sasaki S, Asano S, Kageyama M, Iijima T, Bender A
J Chem Inf Model. 2024; 64(18):7068-7076.
PMID: 39254593
PMC: 11423340.
DOI: 10.1021/acs.jcim.4c00921.
Nicoli A, Weber V, Bon C, Steuer A, Gustincich S, Gainetdinov R
J Chem Inf Model. 2023; 63(21):6667-6680.
PMID: 37847527
PMC: 10647090.
DOI: 10.1021/acs.jcim.3c00755.
Ejaz S, Paracha R, Ejaz S, Jamal Z
PLoS One. 2023; 18(9):e0291213.
PMID: 37682810
PMC: 10490861.
DOI: 10.1371/journal.pone.0291213.
Tiwari V, Sowdhamini R
Comput Struct Biotechnol J. 2023; 21:2204-2214.
PMID: 37013002
PMC: 10066510.
DOI: 10.1016/j.csbj.2023.03.005.
Development of SOS1 Inhibitor-Based Degraders to Target -Mutant Colorectal Cancer.
Bian Y, Alem D, Beato F, Hogenson T, Yang X, Jiang K
J Med Chem. 2022; 65(24):16432-16450.
PMID: 36459180
PMC: 10113742.
DOI: 10.1021/acs.jmedchem.2c01300.
Introducing a Chemically Intuitive Core-Substituent Fingerprint Designed to Explore Structural Requirements for Effective Similarity Searching and Machine Learning.
Janela T, Takeuchi K, Bajorath J
Molecules. 2022; 27(7).
PMID: 35408730
PMC: 9000322.
DOI: 10.3390/molecules27072331.
From Data to Knowledge: Systematic Review of Tools for Automatic Analysis of Molecular Dynamics Output.
Baltrukevich H, Podlewska S
Front Pharmacol. 2022; 13:844293.
PMID: 35359865
PMC: 8960308.
DOI: 10.3389/fphar.2022.844293.
Virtual Screening of Transmembrane Serine Protease Inhibitors.
Poso A, Tervonen T, Klefstrom J
Bio Protoc. 2021; 7(8):e2246.
PMID: 34541238
PMC: 8410343.
DOI: 10.21769/BioProtoc.2246.
Targeting SARS-CoV-2 Spike Protein/ACE2 Protein-Protein Interactions: a Computational Study.
Pirolli D, Righino B, De Rosa M
Mol Inform. 2021; 40(6):e2060080.
PMID: 33904240
PMC: 8206717.
DOI: 10.1002/minf.202060080.
Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease.
Delre P, Caporuscio F, Saviano M, Mangiatordi G
Front Chem. 2020; 8:594009.
PMID: 33304884
PMC: 7701290.
DOI: 10.3389/fchem.2020.594009.
Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide.
DAloia A, Arrigoni F, Tisi R, Palmioli A, Ceriani M, Artusa V
Int J Mol Sci. 2020; 21(23).
PMID: 33260658
PMC: 7730713.
DOI: 10.3390/ijms21239074.
Demystifying the Molecular Basis of Pyrazoloquinolinones Recognition at the Extracellular α1+/β3- Interface of the GABA Receptor by Molecular Modeling.
Singh N, Villoutreix B
Front Pharmacol. 2020; 11:561834.
PMID: 33041802
PMC: 7518038.
DOI: 10.3389/fphar.2020.561834.
New classes of potent heparanase inhibitors from ligand-based virtual screening.
Pala D, Scalvini L, Elisi G, Lodola A, Mor M, Spadoni G
J Enzyme Inhib Med Chem. 2020; 35(1):1685-1696.
PMID: 32907434
PMC: 7534336.
DOI: 10.1080/14756366.2020.1811701.
Enhancing the Signaling of GPCRs via Orthosteric Ions.
Chan H, Xu Y, Tan L, Vogel H, Cheng J, Wu D
ACS Cent Sci. 2020; 6(2):274-282.
PMID: 32123746
PMC: 7047428.
DOI: 10.1021/acscentsci.9b01247.
Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors.
Caballero J
Molecules. 2020; 25(2).
PMID: 31940798
PMC: 7024173.
DOI: 10.3390/molecules25020295.
Structural Requirements of -alpha-Mercaptoacetyl Dipeptide (NAMdP) Inhibitors of Virulence Factor LasB: 3D-QSAR, Molecular Docking, and Interaction Fingerprint Studies.
Velazquez-Libera J, Murillo-Lopez J, F de la Torre A, Caballero J
Int J Mol Sci. 2019; 20(24).
PMID: 31817391
PMC: 6940830.
DOI: 10.3390/ijms20246133.
Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1).
Singh N, Villoutreix B, Ecker G
Sci Rep. 2019; 9(1):15061.
PMID: 31636293
PMC: 6803698.
DOI: 10.1038/s41598-019-51455-8.
Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33.
Velazquez-Libera J, Rossino G, Navarro-Retamal C, Collina S, Caballero J
Front Chem. 2019; 7:496.
PMID: 31355187
PMC: 6637851.
DOI: 10.3389/fchem.2019.00496.
Computational modeling of the olfactory receptor Olfr73 suggests a molecular basis for low potency of olfactory receptor-activating compounds.
Yuan S, Dahoun T, Brugarolas M, Pick H, Filipek S, Vogel H
Commun Biol. 2019; 2:141.
PMID: 31044166
PMC: 6478719.
DOI: 10.1038/s42003-019-0384-8.